Viking Therapeutics, Inc. ("Viking") (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders, today announced ...

We found the best ranges by boiling water, melting chocolate, and baking thousands of cookies and cakesThe GE Profile ...

Fintel reports that on November 12, 2024, Morgan Stanley upgraded their outlook for Viking Holdings (NYSE:VIK) from ...

Viking Therapeutics (VKTX) surges on promising obesity drug results. Explore key price levels and analyst insights in this detailed analysis.

More Viking Age silver has been discovered per square kilometer on the Isle of Man than in England, Ireland, Scotland, and ...

TPG's Ashley Kosciolek accepted a free trip from Viking Cruises to sail on Viking Mississippi. The opinions expressed below ...

We chose the Polar Monkeys Cyber Plunge as the best overall cold plunge tub because it sets the bar for all the essential ...

Sam Darnold has experienced a career revival his his first season with the Minnesota Vikings.

Viking Therapeutics stock is volatile Monday after the pharma company released positive data for its weight-loss drug. Here's ...

Ship-shaped graves have been identified at the site, which came to light during investigations of an earlier Stone Age ...

The biotech had tested the oral asset, dubbed VK2735, at doses ranging from 2.5 mg up to 100 mg. Viking already revealed back in March that 25% of the eight patients who received 20-mg doses saw their ...

On Tuesday, Viking Therapeutics Inc (VKTX) stock saw a decline, ending the day at $60.6 which represents a decrease of $-2.37 or -3.76% from the prior close of $62.97. The stock opened at $62.46 and ...